Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Cd |
| Molecular Weight | 112.411 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 2 |
SHOW SMILES / InChI
SMILES
[Cd++]
InChI
InChIKey=WLZRMCYVCSSEQC-UHFFFAOYSA-N
InChI=1S/Cd/q+2
| Molecular Formula | Cd |
| Molecular Weight | 112.411 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cadmium is a heavy metal that causes toxicity in humans and animals. Cadmium chloride is used due to its solubility in water and its ability to produce high concentrations of cadmium at the target site. Cadmium chloride is used in printing, photocopying, dyeing, analytical chemistry. Experiments on rodents have shown that this compound caused renal toxicity. Oxidative stress plays a key role in cadmium chloride-induced cyto/genotoxicity.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The protective role of ascorbic acid in the hepatotoxicity of cadmium and mercury in rabbits. | 2019-05 |
|
| Cadmium Chloride Induces DNA Damage and Apoptosis of Human Liver Carcinoma Cells via Oxidative Stress. | 2016-01-02 |
|
| Effects of Maternal Exposure to Cadmium Oxide Nanoparticles During Pregnancy on Maternal and Offspring Kidney Injury Markers Using a Murine Model. | 2015 |
|
| Cadmium associated with inhaled cadmium oxide nanoparticles impacts fetal and neonatal development and growth. | 2012-04 |
|
| Effects of particulate and soluble cadmium species on biochemical and functional parameters in cultured murine macrophages. | 2000 |
|
| Inhibition of HIV-1 infection by zinc group metal compounds. | 1999-09 |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999-05 |
|
| Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. | 1991-09-10 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:53:37 GMT 2025
by
admin
on
Mon Mar 31 20:53:37 GMT 2025
|
| Record UNII |
T494FZ4G8G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
48775
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | |||
|
DTXSID60177060
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | |||
|
22537-48-0
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | |||
|
T494FZ4G8G
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | |||
|
T494FZ4G8G
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | |||
|
31193
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | |||
|
1546276
Created by
admin on Mon Mar 31 20:53:37 GMT 2025 , Edited by admin on Mon Mar 31 20:53:37 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
